Characterisation of colloidal drug delivery systems from the naked eye to Cryo-FESEM

Micron

Volumn 38, Issue 8, 2007, Pages 796-803

  Krauel, Karen ^a   Girvan, Liz ^a   Hook, Sarah ^a   Rades, Thomas ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Colloidal systems; Electron microscopy; Microemulsions; Nanoparticles

Indexed keywords

BUTENES; LIQUID CRYSTALS; MICROEMULSIONS; NANOPARTICLES; PHASE BOUNDARIES; POLYMERIZATION; TRANSMISSION ELECTRON MICROSCOPY;

COLLOIDAL SYSTEMS; POLYETHYLCYANOACRYLATE; POLYOXYETHYLENE; PSEUDOTERNARY SYSTEMS;

DRUG DELIVERY;

NANOPARTICLE;

ARTICLE; CRYOELECTRON MICROSCOPY; DRUG DELIVERY SYSTEM; EMULSION; FREEZE FRACTURE; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

CRYOELECTRON MICROSCOPY; DRUG DELIVERY SYSTEMS; EMULSIONS; FREEZE FRACTURING; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES;

EID: 35148821884     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micron.2007.06.008     Document Type: Article

References (27)

1. Aboubakar M., Couvreur P., Pinto-Alphandary H., Gouritin B., Lacour B., Farinotti R., Puisieux F., and Vauthier C. Insulin-loaded nanocapsules for oral administration: in vitro and in vivo investigation. Drug Dev. Res. 49 (2000) 109-117
2. Alany R.G., Tucker I.G., Davies N.M., and Rades T. Characterizing colloidal structures of pseudoternary phase diagrams formed by oil/water/amphiphile systems. Drug Dev. Ind. Pharm. 27 (2001) 31-38
3. Amidon G.L., Lennernaes H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995) 413-420
4. Behan N., Birkinshaw C., and Clarke N. Poly n-butyl cyanoacrylate nanoparticles: a mechanistic study of polymerisation and particle formation. Biomaterials 22 (2001) 1335-1344
5. Bootz A., Vogel V., Schubert D., and Kreuter J. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butylcyanoacrylate) nanoparticles. Eur. J. Pharm. Biopharm. 57 (2004) 369-375
6. Bootz A., Russ T., Gores F., Karas M., and Kreuter J. Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography. Eur. J. Pharm. Biopharm. 60 (2005) 391-399
7. Burauer S., Belkoura L., Stubenrauch C., and Strey R. Bicontinuous microemulsions revisited: a new approach to freeze-fracture electron microscopy (FFEM). Colloids Surf. A: Physicochem. Eng. Aspects 228 (2003) 159-170
8. Chouinard F., Kan F.W.K., Leroux J.-C., Foucher C., and Lenaerts V. Preparation and purification of polyisohexylcyanoacrylate nanocapsules. Int. J. Pharm. 72 (1991) 211-217
9. Cleland J.L., Daugherty A., and Mrsny R. Emerging protein delivery methods. Curr. Opin. Biotechnol. 12 (2001) 212-219
10. Constantinides P.P., Scalart J.P., Lancaster C., Marcello J., Marks G., Ellens H., and Smith P.L. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm. Res. 11 (1994) 1385-1390
11. Couvreur P., Tulkens P., Roland M., Trouet A., and Speiser P. Nanocapsules: a new type of lysosomotropic carrier. FEBS Lett. 84 (1977) 323-326
12. Couvreur P., Dubernet C., and Puisieux F. Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur. J. Pharm. Biopharm. 41 (1995) 2-13
13. Damge C., Aprahamian M., Balboni G., Höltzel A., Andrieu V., and Devissaguet J.P. Polyalkylcyanoacrylate nanocapsules increase the intestinal absorption of a lipophilic drug. Int. J. Pharm. 36 (1987) 121-125
14. Damge C., Michel C., Aprahamian M., and Couvreur P. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes 37 (1988) 246-251
15. Gasco M.R., and Trotta M. Nanoparticles from microemulsions. Int. J. Pharm. 29 (1986) 267-268
16. Jani P., Halbert G.W., Langridge J., and Florence A.T. Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J. Pharm. Pharmacol. 42 (1990) 821-826
17. Krauel K., Pitaksuteepong T., Davies N.D., and Rades T. Entrapment of bioactive molecules in poly (alkylcyanoacrylate) nanoparticles. Am. J. Drug Deliv. 2 (2004) 251-258
18. Krauel K., Davies N.M., and Rades T. Using different structure types of microemulsions for the preparation of poly (alkylcyanoacrylate) nanoparticles by interfacial polymerisation. J. Control. Release 106 (2005) 76-87
19. Krauel K., Graf A., Hook S., Davies N.M., and Rades T. Preparation of poly(alkylcyanoacrylate) nanoparticles by polymerisation of water-free microemulsions. J. Microencapsul. 23 5 (2006) 499-512
20. Lindmann B., Stilbs P., and Moseley M. Fourier transform NMR self-diffusion and microemulsion structure. J. Colloid Interface Sci. 83 (1981) 569-582
21. Müller-Goymann C.C. Anwendung lyotroper flüssigkristalle in pharmazie und medizin. In: Stegemeyer H. (Ed). Lyotrope Flüssigkristalle (1999), Steinkopff Verlag, Darmstadt 141-167
22. O'Hagan D.T., Palin K.J., and Davis S.S. Poly(butyl-2-cyanoacrylate) particles as adjuvants for oral immunisation. Vaccine 7 (1989) 213-216
23. Stilbs P. A comparative study of micellar solubilisation for combination of surfactants and solubilisates using fourier transfom pulsed-gradient spin-echo NMR multicomponent self-diffusion technique. J. Colloid Interface Sci. 94 (1986) 463-469
24. Vauthier C., Dubernet C., Fattal E., Pinto-Alphandary P., and Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv. Drug Deliv. Rev. 55 (2003) 519-548
25. Watnasirichaikul S., Davies N.M., Rades T., and Tucker I.G. Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. Pharm. Res. 17 (2000) 684-689
26. Watnasirichaikul S., Rades T., Tucker I.G., and Davies N.M. Effects of formulation variables on characteristics of poly(ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions. Int. J. Pharm. 235 (2002) 237-246
27. Zhang Q., Shen Z., and Nagai T. Prolonged hypoglycaemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. Int. J. Pharm. 218 (2001) 75-80